Literature DB >> 2854631

Stability of prostacyclin analogues: an unusual lack of reactivity in acid-catalyzed alkene hydration.

A Magill1, C O'Yang, M F Powell.   

Abstract

Prostacyclin analogue 5 undergoes specific acid-catalyzed hydration (kH+ = 1.9 x 10(-7)M-1 sec-1 at 25 degrees C) and a pH-independent oxidation reaction (k0 = 1.2 x 10(-10) sec-1 at 25 degrees C) above pH approximately 5. The hydration reaction for 5 is much slower than for other structurally similar exocyclic alkenes, even though the rate-determining step is proton transfer. This slowness of reaction and an analysis of the pH-rate profile show that 5 does not exhibit significant intramolecular general acid catalysis, as does prostacyclin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854631     DOI: 10.1023/a:1015937628492

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Synthesis of a new chemically and metabolically stable prostacyclin analogue with high and long-lasting oral activity.

Authors:  W Skuballa; E Schillinger; C S Stürzebecher; H Vorbrüggen
Journal:  J Med Chem       Date:  1986-03       Impact factor: 7.446

2.  Chemical stability of prostacyclin (PGI2) in aqueous solutions.

Authors:  M J Cho; M A Allen
Journal:  Prostaglandins       Date:  1978-06

3.  Prostacyclin therapy in peripheral arterial disease.

Authors:  A Szczeklik; R J Gryglewski; R Nizankowski; S Skawiński; P Głuszko; R Korbut
Journal:  Thromb Res       Date:  1980 Jul 1-15       Impact factor: 3.944

4.  Prostacyclin infusion during cardiopulmonary bypass in man.

Authors:  K Rådegran; C Papaconstantinou
Journal:  Thromb Res       Date:  1980 Jul 1-15       Impact factor: 3.944

5.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

6.  Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.

Authors:  A E Gimson; P G Langley; R D Hughes; J Canalese; P J Mellon; R Williams; H F Woods; M J Weston
Journal:  Lancet       Date:  1980-01-26       Impact factor: 79.321

7.  The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.

Authors:  A G Olsson; E Nilsson
Journal:  Prostaglandins Med       Date:  1981-04

8.  A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.

Authors:  V Hossman; A Heinen; H Auel; G A FitzGerald
Journal:  Thromb Res       Date:  1981-05-15       Impact factor: 3.944

9.  Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.

Authors:  A K Sim; A P McCraw; M E Cleland; S Nishio; T Umetsu
Journal:  Arzneimittelforschung       Date:  1985
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.